Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Augmented frontal cortex diacylglycerol levels in Parkinson’s disease and Lewy Body Disease
Paul L. Wood, Soumya Tippireddy, Joshua Feriante, et al.
PLoS ONE (2018) Vol. 13, Iss. 3, pp. e0191815-e0191815
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
Yaping Shao, Weidong Le
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 208
The Role of Lipids in Parkinson’s Disease
Helena Xicoy, Bé Wieringa, Gerard J.M. Martens
Cells (2019) Vol. 8, Iss. 1, pp. 27-27
Open Access | Times Cited: 201
Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
Irina Alecu, Steffany A. L. Bennett
Frontiers in Neuroscience (2019) Vol. 13
Open Access | Times Cited: 200
Parkinson’s disease: proteinopathy or lipidopathy?
Saranna Fanning, Dennis J. Selkoe, Ulf Dettmer
npj Parkinson s Disease (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 184
Disrupted myelin lipid metabolism differentiates frontotemporal dementia caused by GRN and C9orf72 gene mutations
Oana C. Marian, Jonathan D. Teo, Jun Yup Lee, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 28
Spatial lipidomics reveals brain region-specific changes of sulfatides in an experimental MPTP Parkinson’s disease primate model
Ibrahim Kaya, Anna Nilsson, Dominika Luptáková, et al.
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 26
The Inflammatory Mechanism of Parkinson’s Disease: Gut Microbiota Metabolites Affect the Development of the Disease Through the Gut–Brain Axis
Ai Gao, Jiaqi Lv, Yanwei Su
Brain Sciences (2025) Vol. 15, Iss. 2, pp. 159-159
Open Access | Times Cited: 1
Metabolomics in Parkinson’s Disease and Correlation with Disease State
Elena A. Ostrakhovitch, Kenjiro Ono, Tritia R. Yamasaki
Metabolites (2025) Vol. 15, Iss. 3, pp. 208-208
Open Access | Times Cited: 1
Altered ceramide metabolism is a feature in the extracellular vesicle-mediated spread of alpha-synuclein in Lewy body disorders
Marzena Kurzawa‐Akanbi, Seshu R. Tammireddy, Ivo Fabrik, et al.
Acta Neuropathologica (2021) Vol. 142, Iss. 6, pp. 961-984
Open Access | Times Cited: 42
Ceramide Metabolism and Parkinson’s Disease—Therapeutic Targets
Antía Custodia, Marta Aramburu-Núñez, Clara Correa‐Paz, et al.
Biomolecules (2021) Vol. 11, Iss. 7, pp. 945-945
Open Access | Times Cited: 41
The role of NURR1 in metabolic abnormalities of Parkinson’s disease
Murad Al‐Nusaif, Yuting Yang, Song Li, et al.
Molecular Neurodegeneration (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 31
Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease
Kuo‐Hsuan Chang, Mei‐Ling Cheng, Hsiang-Yu Tang, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 395-395
Open Access | Times Cited: 28
Targeted metabolomic analysis in Parkinson’s disease brain frontal cortex and putamen with relation to cognitive impairment
Karel Kalecký, Teodoro Bottiglieri
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 20
Lipids shape brain function through ion channel and receptor modulations: physiological mechanisms and clinical perspectives
Salvatore Incontro, Maria Laura Musella, Malika Sammari, et al.
Physiological Reviews (2024) Vol. 105, Iss. 1, pp. 137-207
Closed Access | Times Cited: 6
Alteration in the Cerebrospinal Fluid Lipidome in Parkinson’s Disease: A Post-Mortem Pilot Study
Joaquín Fernández‐Irigoyen, Paz Cartas‐Cejudo, Marta Iruarrizaga‐Lejarreta, et al.
Biomedicines (2021) Vol. 9, Iss. 5, pp. 491-491
Open Access | Times Cited: 39
The Bidirectional Interplay of α-Synuclein with Lipids in the Central Nervous System and Its Implications for the Pathogenesis of Parkinson’s Disease
Kristina Battis, Wei Xiang, Jürgen Winkler
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 17, pp. 13270-13270
Open Access | Times Cited: 16
A Perspective on the Link between Mitochondria-Associated Membranes (MAMs) and Lipid Droplets Metabolism in Neurodegenerative Diseases
Tânia Fernandes, M. Rosário M. Domingues, Paula I. Moreira, et al.
Biology (2023) Vol. 12, Iss. 3, pp. 414-414
Open Access | Times Cited: 14
Vesicle trafficking and lipid metabolism in synucleinopathy
Saranna Fanning, Dennis J. Selkoe, Ulf Dettmer
Acta Neuropathologica (2020) Vol. 141, Iss. 4, pp. 491-510
Open Access | Times Cited: 35
Wild-type GBA1 increases the α-synuclein tetramer–monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice
Kelly E. Glajch, Tim E. Moors, Yi Chen, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 31
Open Access | Times Cited: 32
Plasma Lipidomics Approach in Early and Specific Alzheimer’s Disease Diagnosis
Carmen Peña‐Bautista, Lourdes Álvarez‐Sánchez, Marta Roca, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 17, pp. 5030-5030
Open Access | Times Cited: 21
Exploring the Dynamic Changes of Brain Lipids, Lipid Rafts, and Lipid Droplets in Aging and Alzheimer’s Disease
Michele Cerasuolo, Irene Di Meo, Maria Chiara Auriemma, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1362-1362
Open Access | Times Cited: 4
Investigating plasma lipid profiles in association with Parkinson’s disease risk
Houwen Zhang, Fangzheng Cao, Jialin Yu, et al.
npj Parkinson s Disease (2025) Vol. 11, Iss. 1
Open Access
Increased burden of rare risk variants across gene expression networks predisposes to sporadic Parkinson’s disease
Elena Eubanks, Katelyn VanderSleen, Jiya Mody, et al.
Cell Reports (2025) Vol. 44, Iss. 5, pp. 115636-115636
Open Access
Synaptic vesicle-omics in mice captures signatures of aging and synucleinopathy
Virginia Gao, Julita Chlebowicz, Kerry Gaskin, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Comprehensive Serum Lipidomics for Detecting Incipient Dementia in Parkinson’s Disease
Adriana Zardini Buzatto, Jaspaul Tatlay, Barinder Bajwa, et al.
Journal of Proteome Research (2021) Vol. 20, Iss. 8, pp. 4053-4067
Closed Access | Times Cited: 25
Page 1 - Next Page

Scroll to top